Neurocrine Biosciences Inc (NBIX)
117.44
-5.44
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
117.22
-0.22
(-0.19%)
After-Hours: 20:00
Neurocrine Biosciences Cash and Short Term Investments (Quarterly): 1.228B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.228B |
| June 30, 2024 | 1.039B |
| March 31, 2024 | 1.211B |
| December 31, 2023 | 1.032B |
| September 30, 2023 | 1.095B |
| June 30, 2023 | 976.70M |
| March 31, 2023 | 894.60M |
| December 31, 2022 | 989.30M |
| September 30, 2022 | 799.40M |
| June 30, 2022 | 648.30M |
| March 31, 2022 | 664.90M |
| December 31, 2021 | 711.30M |
| September 30, 2021 | 765.90M |
| June 30, 2021 | 884.90M |
| March 31, 2021 | 873.70M |
| December 31, 2020 | 801.00M |
| September 30, 2020 | 944.70M |
| June 30, 2020 | 948.30M |
| March 31, 2020 | 771.70M |
| December 31, 2019 | 670.50M |
| September 30, 2019 | 670.16M |
| June 30, 2019 | 619.98M |
| March 31, 2019 | 524.07M |
| December 31, 2018 | 650.91M |
| September 30, 2018 | 635.34M |
| Date | Value |
|---|---|
| June 30, 2018 | 508.74M |
| March 31, 2018 | 460.48M |
| December 31, 2017 | 515.93M |
| September 30, 2017 | 511.02M |
| June 30, 2017 | 525.02M |
| March 31, 2017 | 235.58M |
| December 31, 2016 | 307.35M |
| September 30, 2016 | 353.04M |
| June 30, 2016 | 387.40M |
| March 31, 2016 | 381.52M |
| December 31, 2015 | 379.19M |
| September 30, 2015 | 376.84M |
| June 30, 2015 | 384.72M |
| March 31, 2015 | 370.01M |
| December 31, 2014 | 193.81M |
| September 30, 2014 | 179.67M |
| June 30, 2014 | 194.66M |
| March 31, 2014 | 219.86M |
| December 31, 2013 | 145.74M |
| September 30, 2013 | 156.91M |
| June 30, 2013 | 153.70M |
| March 31, 2013 | 158.23M |
| December 31, 2012 | 173.01M |
| September 30, 2012 | 173.96M |
| June 30, 2012 | 177.54M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
648.30M
Minimum
Jun 2022
1.228B
Maximum
Sep 2024
897.47M
Average
889.75M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Repligen Corp | 783.96M |
| West Pharmaceutical Services Inc | 490.90M |
| Bruker Corp | 148.10M |
| The Cooper Companies Inc | 109.70M |
| Integra Lifesciences Holdings Corp | 277.60M |